Microstructure Imaging

About Microstructure Imaging

MICSI (Microstructure Imaging, Inc.) specializes in advanced denoising solutions for diffusion MRI (dMRI) and functional MRI (fMRI), primarily aimed at improving presurgical planning for neurosurgery and characterizing prostate microstructure. The company addresses the limitations posed by the accessibility of high-quality MRI systems, enabling high signal-to-noise ratio (SNR) imaging even on lower field strength MRI scanners. MICSI's technology leverages Random Matrix Theory and Marchenko Pastur Principal Component Analysis to enhance the quality of MRI images, making them more reliable for clinical use. The primary clients include hospitals, research institutions, and medical imaging centers that require precise imaging for diagnostic and surgical planning purposes. Operating in the medical imaging market, MICSI's business model revolves around selling its proprietary denoising software and licensing its technology to MRI manufacturers and healthcare providers. Revenue is generated through software sales, licensing fees, and potentially through partnerships with medical device companies.